| Date |
Description |
Institution |
# Students |
| 8/2013 - Present |
Ph.D. Dissertations Directed |
UTHSCSA |
|
|
| 5/2013 - Present |
Pre-Doctoral Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 5/2013 - Present |
Pre-Doctoral Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 9/2012 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 3/2012 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 1/2012 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 10/2011 - Present |
Pre-Doctoral Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 10/2011 - Present |
Pre-Doctoral Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 7/2011 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 9/2010 - Present |
Post-Doctoral Student Supervision |
University of Texas Health Science Center |
|
|
| 7/2010 - Present |
Individual Instruction |
The University of Texas Health Science Center, San Antonio, TX |
|
|
| 6/2010 - Present |
Membership on Supervising Committee |
The University of Texas Health Science Center |
|
|
| 1/2010 - Present |
Pre-Doctoral Student Supervision |
The University of Texas Health Science Center, San Antonio, TX |
|
|
| 9/2009 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 6/2009 - Present |
Introduction to Clinical Laboratory Sciences |
The University of Texas Health Science Center |
18 students |
| Lectured on recent advances in natural products for cancer management |
| 3/2009 - Present |
Pre-Doctoral Student Supervision |
The University of Texas Health Science Center, San Antonio TX |
|
|
| 3/2009 - Present |
Cancer Biology Core II |
The University of Texas Health Science Center |
11 students |
| Lectured on GU malignancies with special reference to prostate cancer and treatment strategies |
| 9/2008 - Present |
Rotation Student Supervision |
University of Texas Health Science Center, San Antonio, TX |
|
|
| 6/2008 - Present |
Cancer Biology Core II |
The University of Texas Health Science Center |
3 students |
| Lectured on molecular events associated with prostate cancer development, detection methods and preventive strategies |
| 4/2008 - Present |
Individual Instruction |
The University of Texas Health Science Center, San Antonio, TX |
|
|
| 1/2007 - Present |
Individual Instruction |
The University of Texas Health Science Center, San Antonio, TX |
|
|
Journal Article |
| Chen C-L, Mahalingam D, Osmulski PA, Jadhav RR, Wang C-M, Leach RJ, Weitman SD, Kumar P, Sun L-Z, Gaczynska ME, Thompson J, Huang TH. Single-cell Analysis of Circulating Tumor Cells Identifies Cumulative Expression Patterns of EMT-related Genes in Metastatic Prostate Cancer The Prostate 2013 Jan;73(8):813-826.
|
| Li, G, Rivas, P, Bedolla, R, Thapa, D, Reddick RL, Ghosh R, Kumar P. Dietary Resveratrol Prevents Development of High-Grade Prostatic Intraepithelial Neoplastic Lesions: Involvement of SIRT1/S6K Axis Cancer Prevention Research 2012 Jan;.
|
| Bedolla RG, Gong J, Prihoda TJ, Yeh IT, Thompson IM, Ghosh R, Kumar AP. Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence PLOS ONE 2012 Jan;7(9).
|
| Ghosh, R., Graham, H., Rivas, P., Tan, J-X., Crosby, K., Bhaskaran, S., Schoolfield, J., Banu, J., Fernandes, G., Yeh, I-Tien and Kumar, A.P. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management Anticancer Research 2010 Jan;30:847-857.
|
| Sri Balasubashini, M., Kunnumakkara, A. B., Bhaskaran, S. B., Kulkarni, K. H., Xu, H., Hu, M., Aggarwal, B. A., Ghosh, R. and Kumar A. P. Butanol fraction containing berberine or related compound from NexrutineR inhibits NFkB signaling and induces apoptosis in prostate cancer cells Prostate 2009 Jan;69:494-504.
|
| Ganapathy M, Ghosh R, Xie J, Zhang X, Bedolla R, Schoolfield J, Yeh I, Troyer DA, Olumi AF, Kumar P. Involvement of FLIP in 2-methoxyestradiol induced tumor regression in transgenic adenocarcinoma of mouse prostate (TRAMP) model Clin Cancer Res 2009 Jan;15:1601-1611.
|
| Ghosh R
Ganapathy M
Alworth WL
Chan DC
Kumar AP. Combination of 2-methoxyestradiol (2-ME(2)) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells J Steroid Biochem Mol Biol 2009 Jan;113(1-2):25-35.
|
| Yeh I, Reddick RL, Kumar P. Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model The Prostate 2009 Jan;69:755-760.
|
| Kumar P, Schoolfield J, Yeh I, Ghosh R. Loss of NADPH Quinone Oxidoreductase (NQO1) in the prostate and enhanced serum levels of cytokine-induced neutrophil chemoattractant-2alpha(CINC-2alpha) in hormone stimulated Noble rats: potential role in PIN development Translational Oncology 2009 Jan;2:65-72.
|
Abstract |
| Batth IS, Gong J, Kumar, Ph.D. AP. Novel interaction between FLIP/DAPK: role for RON in androgen-independent prostate cancer; 2013 Apr. (American Association for Cancer Research 104th Annual Meeting, Washington, DC).
|
| Batth IS, Gong J, Kumar, Ph.D. AP. RON Kinase Propagates Prostate Tumorigenesis through Interations with AR and FLIP; 2012 Nov. (Advances in Cell Signaling, Cancer Prevention & Therapy 13th Annual Meeting, South Padre Island, Tx).
|
| Gong J, Xie J, Batth IS, Freeman JW, Kumar, Ph.D. AP. Disruption of NFB/Stat3 interaction as a potential therapeutic avenue for pancreatic cancer management; 2012 Jun. (Pancreatic Cancer: Progress and Challenges, Lake Tahow, NV).
|
| Batth IS, Gong J, Bedolla RG, Weintraub ST, Kumar, Ph.D. AP. 2-Methoxyestradiol targets RON kinase and FLIP to inhibit epithelial-mesenchymal transition in Prostate Cancer; 2012 Apr. (American Association for Cancer Research 103rd Annual Meeting, Chicago, IL).
|
| Batth IS, Weintraub ST, Kumar, Ph.D. AP. 2-Methoxyestradiol targets RON kinase and FLIP to inhibit epithelial-mesenchymal transition in Prostate Cancer; 2011 Nov. (Advances in Cell Signaling, Cancer Prevention).
|
| Gong J, Batth IS, Kumar, Ph.D. AP. Jak/STAT3 signaling: A potential target for pancreatic cancer management; 2011 Apr. (American Associaton for Cancer Research 102 nd Annual Meeting, Orlando, FL).
|
| Xie, J., Rivas, P., Soundararajan, A., David, M.D., Yeh, I-T., Ghosh, R and Kumar, A.P. Interactions among transcription factors as a potential mechanism for inhibiting castrate-resistant prostate cancer (CRPCa) in transgenic adenocarcinoma of mouse prostate (TRAMP) through regulation of FLIP; 2011 Apr. (102ND Annual meeting of the American Association for Cancer Research).
|
| Xie, J., Ghosh, R. and Kumar, A.P. 2-Methoxyestradiol (2-ME2) induces microRNA alterations in prostate cancer cells: Role for miRs in 2-ME2-induced biological effects; 2011 Apr. (102ND Annual meeting of the American Association for Cancer Research).
|
| Gong, J., Batth, I.S. and Kumar, A.P. Jak/Stat signaling: a potential target for pancreatic cancer management; 2011 Apr. (102ND Annual meeting of the American Association for Cancer Research).
|
| A. Gupta, M. Mann, A.P. Kumar, B.O. Oyajobi. Anti-tumor effect of Nextrutine, a Phellodendron amurense Bark Extract; 2011 Jan. (102ND Annual meeting of the American Association for Cancer Research, April 2011).
|
| Kumar, A.P., Swanson, G.P., Thompson, I.M. and Ghosh, R. Molecular targeted approaches for cancer management; 2011 Jan. (Invited presentation at Plenary session at 98th Indian Science Congress January 2011).
|
| Jingjing Gong, James W Freeman and Kumar, Ph.D. AP. NF-kappaB and Stat3 interaction: a potential target for pancreatic cancer management; 2010 Nov. (Advances in cell signaling, Cancer prevention and therapeutics Annual Meeting, South Padre Island, Tx).
|
| Gong, J., Freeman, J.W. and Kumar, A.P. NFkB and Stat3 interaction: a potential target for pancreatic cancer management; 2010 Nov. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy).
|
| Kumar, S., Ghosh, R. and Kumar, A.P. 2-Methoxyestradiol inhibits proliferation and induces apoptosis through modulation of miR-7/FLIP signaling in prostate cancer cells; 2010 May. (101st annual meeting of the American Association of Cancer Research Washington DC, April 17-21 2010).
|
| Jingjing Gong, James W Freeman and Kumar, Ph.D. AP. Enhanced inhibition of proliferation of pancreatic cancer cells by combination of Gemcitabine and Phellodendron amurense bark extract:: target identification; 2010 Apr. (American Association for Cancer Research Annual Meeting. Orlando, FL).
|
| Li, G., Ghosh, R., Kumar, A.P. Differential effects of resveratrol-induced SIRT1 in prostate cancer: A novel therapuetic target; 2010 Jan. (Proceedings of 101st Annual Meeting of American Association for Cancer Research).
|
| Kumar, S.A., Ghosh, R., Kumar, A.P. 2-Methoxyestradiol inhibits proliferation and induces apoptosis through modulation of miR-7/FLIP signaling in prostate cancer cells; 2010 Jan. (Proceedings of 101st Annual Meeting of American Association for Cancer Research).
|
| Xie, J., Ghosh, R., Kumar, A.P. FLIP transcriptional regulation: A potential mechanism for development of androgen independent prostate cancer; 2010 Jan. (Proceedings of 101st Annual Meeting of American Association for Cancer Research).
|
| Rita Ghosh, Emily Clark, Heather L Graham, Addanki P Kumar. NexrutineR: a novel agent for malignant melanoma 7th International Melanoma Congress, November 4-7, 2010 Sydney, Australia Pigment Cell and Melanoma Research 23: 952-53; 2010 Jan.
|
| Kumar, A.P., Xie, J., Graham, H., Rivas, P., Li, G,. Robson, C.H., Gong, J., Garapati, K,. Swanson, G.P., Thompson, I.M., Papanikolaou, N., Yeh, I-T. and Ghosh, R. Bench to bedside application of Phellodendron amurense bark extract: myth or reality?; 2010 Jan. (Invited presentation at 2nd International ICR symposium December 2010).
|
| Polnaszek, N., Soomro, N., Bermejo, C.E., Kumar, A.P. and Ghosh, R. 8-methyl-N-vannillyl 6-nonemide (capsaicin) induces apoptosis in bladder cancer cells independent of p53 status: implications for therapy; 2010 Jan. (Annual Meeting of the American Urological Association, San Francisco, May 29-June 3, 2010).
|
| Xie, J., Ghosh, R. and Kumar, A.P. FLIP transcriptional deregulation: A potential mechanism for development of androgen independent prostate cancer; 2010 Jan. (101st annaul meeting of the American Association of Cancer Research, Washington DC, April 17-21, 201).
|
| Ghosh, R., Clark, E., Graham, H. and Kumar, A.P. NexrutineR: A novel agent for malignant melanoma; 2010 Jan. (7th International Melanoma Congress, Sydney, Nov 4-7, 2010).
|
| Graham, H.L., Kumar, A.P. and Ghosh, R. mTOR mediated signaling in the management of malignant melanoma; 2010 Jan. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy).
|
| Gong, J., Freeman JW and Kumar, AP. NFkB and Stat3 interaction: a potential target for pancreatic cancer management. 12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy. November 12-13th 2010; 2010 Jan.
|
| Ghosh, R., Clark, E., Graham, H.L. and Kumar, A.P. NexrutineR: a novel agent for malignant melanoma; 2010 Jan. (7th International Melanoma CongressSydney, Australia Pigment Cell and Melanoma Research).
|
| Xie, J., Ghosh, R. and Kumar, Ph.D. AP. 2-Methoxyestradiol modulated microRNAs in prostate cancer cells; 2010 Jan. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer).
|
| Xie, J., Ghosh R., and Kumar AP. 2010. 2-Methoxyestradiol modulated microRNAs in prostate cancer cells. 12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer Therapy. November 12-13th 2010; 2010 Jan.
|
| Graham, HL., Kumar AP and Ghosh, R. mTOR mediated signaling in the management of malignant melanoma. 2010; 2010 Jan. (12TH Annual South Padre Island Symposium on Advances in Cell signaling cancer prevention and Cancer).
|
| Jingjing Gong, James W Freeman and Kumar, Ph.D. AP. Prostaglandin signaling: Target for pancreatic cancer; 2009 Nov. (Advances in cell signaling, Cancer prevention and therapeutics Annual Meeting, South Padre Island, Texas).
|
| George, S.K., Kumar, A.P. and Ghosh, R. Multiple roles of E2F1 in eugenol-induced DNA damage signaling and cell survival; 2009 Nov.
|
| Kumar, Ph.D. AP. Prostaglandin signaling: target for pancreatic cancer; 2009 Jan. (Presented at Cell Signaling meeting South Padre Island November 2009).
|
| Manonmani Ganapathy
Jianping Xie
Heather Graham
Aria F Olumi
Rita Ghosh
Addanki P. Kumar. Androgen medicated FLIP expression in androgen-sensitive prostatic cancer cell LNCaP as a novel target for 2-Methoxyestradiol (2-Me2) induced apoptosis. 2009 Proceedings of 100th Annual Meeting of American Association for Cancer Research; 2009 Jan. (Proceedings of American Association for Cancer Research).
|
| Rita Ghosh
Rumu Bose
Addanki P. Kumar. E2F2 in eugenol-induced inhibitory activities in malignant melanoma. 2009 Proceedings of 100th Annual Meeting of the American Association for Cancer Research; 2009 Jan. (Proceedings of American Association for Cancer Research).
|
| CPT Craig H. Robson
Manonmani Ganapathy
Gregory P. Swanson
Niko Papanikolaou
Paul Rivas
Martha A. Hanes
Yeh I-Tien
Rita Ghosh
Addanki P. Kumar. Phellodendoron amurense bark extract as an adjuvant for prostate cancer radio-therapy. 2009 Proceedings of 100th Annual Meeting of the American Association for Cancer Research; 2009 Jan. (Proceedings of American Association for Cancer Research).
|
| Kumar, AP
Ghosh, R
Ganapathy, M
Sribalasubashini, M
Graham, H
Rivas, P
Jianping, X
Robson, C. Targeting cell survival and apoptotic signaling pathways for prostate cancer management; 2009 Jan. (Anticancer Reserch).
|
| Robson, C.H., M.C., U.S.A., Ganapathy, M., Swanson, G.P., Natarajan, N., Papanikolaou, N., Hanes, M., Yeh, I-T., Ghosh, R. and Kumar, A.P. Targeting NF-kappa B regulated genes with Phellodendron amurense bark extract may enhance cytotoxic effects of radiation in prostate cancer: A preclinical animal model; 2009 Jan.
|
| Ghosh, R., Bose, R. and Kumar, Ph.D. AP. E2F2 in eugenol induced growth inhibition in melanoma; 2009 Jan. (100th Annual Meeting of the American Association of Cancer Research Denver).
|
Review Article |
| Jingjing Gong, James W Freeman, Kumar, Ph.D. AP. Interaction between Jak/Stat3 and ROS generation in pancreatic cancer Advances in cell signaling, Cancer prevention and therapeutics Annual Meeting, South Padre Island, Tx 2011 Nov;.
|
| Kumar AP, Graham HL, Robson C, Thompson, IM and Ghosh R. Natural Products: Potential for developing Phellondendron amurense bark extract for prostate cancer management Mini-rev Med Chem 2010 Jan;10:388-397.
|
Not Specified |
| Kumar AP. STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth ONCOTARGET 2014 May;.
|
| Kumar AP. Combined targeting of Stat3/NF B/Cox-2/EP4 for effective management of pancreatic cancer Clinical Cancer Research 2014 Mar;20.
|
| Kumar AP. Palmatine suppresses rpS6/NFκB/FLIP to inhibit growth and invasion in androgen independent prostate cancer cells Molecular Carcinogenesis 2014 Jan;.
|
| Kumar, Ph.D. AP. FLIP MOLECULAR SWITCH BETWEEN APOPTOSIS AND NECROPTOSIS MOLECULAR CARCINOGENESIS 2013 Jan;.
|
